Literature DB >> 11716186

The Tromsø Study: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women.

M Midtby1, J H Magnus, R M Joakimsen.   

Abstract

Background information on how biological factors influence the level of bone turnover markers is crucial in order to make proper use of these measurements. In the present study, which is part of the fourth survey of a general population in Tromsø, Norway, we evaluated the variation in the bone formation markers bone alkaline phosphatase (S-BAP) and osteocalcin (S-OC) in 528 men and 605 women, age 25-74 years. In the Tromsø Study in 1994/5, the whole population above 25 years was initially invited and 7948 individuals attended an extended examination (76.4% of the invited population). The present study population is a random sample of these attendees. The variation with age, gender, height, weight, body mass index and season, and with menopausal status in women, was examined. In men there was a decrease in S-OC up to the age of 56 years with little further change, while S-BAP showed no change with age. Among women, variation in bone markers was mainly observed to change with menopause, with a 41% and 21% increase in the mean level of S-BAP and S-OC, respectively. There was a negative trend in S-OC with body mass index in both men and women. A seasonal change of 20% in the level of both bone markers in men and of S-BAP in postmenopausal women was observed in this region at a far northern latitude. We conclude that, of the factors examined, season and menopausal status must be taken into account when measuring these bone formation markers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716186     DOI: 10.1007/s001980170034

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  12 in total

1.  Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study.

Authors:  G Y Minuk; R Greenberg; J Uhanova; K Hawkins; W D Leslie
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

Review 2.  Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Authors:  P Szulc; K Naylor; N R Hoyle; R Eastell; E T Leary
Journal:  Osteoporos Int       Date:  2017-06-19       Impact factor: 4.507

3.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

4.  Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Authors:  David M Thompson; Hsi-Ming Lee; Julie A Stoner; Lorne M Golub; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontal Res       Date:  2019-04-29       Impact factor: 4.419

5.  Serum bone biomarkers and oral/systemic bone loss in humans.

Authors:  J B Payne; J A Stoner; H-M Lee; P V Nummikoski; R A Reinhardt; L M Golub
Journal:  J Dent Res       Date:  2011-03-21       Impact factor: 6.116

6.  Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2006-08

Review 7.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

8.  Energy restriction reduces fractional calcium absorption in mature obese and lean rats.

Authors:  Mariana Cifuentes; Amy B Morano; Hasina A Chowdhury; Sue A Shapses
Journal:  J Nutr       Date:  2002-09       Impact factor: 4.798

9.  Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study.

Authors:  Sireen Shilbayeh
Journal:  Osteoporos Int       Date:  2003-10-07       Impact factor: 4.507

10.  Combined Effects of Eurycoma longifolia and Testosterone on Androgen-Deficient Osteoporosis in a Male Rat Model.

Authors:  Halimatun Saadiah Abdul Razak; Ahmad Nazrun Shuid; Isa Naina Mohamed
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.